SCHEMBL10007036

SCHEMBL10007036

CCOC(=O)c1cnc(Cc2cccc(Cl)c2)[nH]c1=O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 1/20 0.64
▸ PDE3A Q14432 1/20 0.64
▸ ALDH1A1 P00352 4/20 0.55
▸ GAA P10253 1/20 0.55
▸ KMT2A Q03164 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ MAPT P10636 3/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ KDM4E B2RXH2 4/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ ALOX5 P09917 3/20 0.49
▸ POLB P06746 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ PTGES O14684 1/20 0.48
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA6 P23280 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15358478 0.83 PDE3B (0.54) PDE3BPDE3AALDH1A1KMT2ASMN1; SMN2
SCHEMBL22272518 0.78 PDE3B (0.59) PDE3BPDE3AALDH1A1KMT2ASMN1; SMN2
SCHEMBL30091528 0.78 PDE3B (0.59) PDE3BPDE3AALDH1A1KMT2ASMN1; SMN2
SCHEMBL23900636 0.78 ALDH1A1 (0.63) ALDH1A1GAAKMT2AMAPTMAPK1
SCHEMBL2902593 0.77 ALDH1A1 (0.66) ALDH1A1GAAKMT2AMAPTMAPK1
SCHEMBL10006709 0.76 MAPT (0.53) PDE3BPDE3AALDH1A1KMT2ASMN1; SMN2
SCHEMBL6706506 0.75 GAA (0.63) ALDH1A1GAAKMT2AMAPTMAPK1
SCHEMBL4518642 0.75 PIP4K2A (0.66) PDE3BPDE3AALDH1A1GAAKMT2A
SCHEMBL46289 0.75 PDE5A (0.76) PDE3BPDE3AALDH1A1KMT2ASMN1; SMN2
SCHEMBL4515609 0.75 PDE5A (0.76) PDE3BPDE3AALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2476682-B1 8-OXODIHYDROPURINE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2017-04-26 — — EP disclosed
EP-2476682-B1 8-OXODIHYDROPURINE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2017-04-26 — — EP disclosed
US-8735406-B2 8-oxodihydropurine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-05-27 — — US disclosed
US-8735406-B2 8-oxodihydropurine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-05-27 — — US disclosed
US-8735406-B2 8-oxodihydropurine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-05-27 — — US disclosed
EP-2476682-A1 8-OXODIHYDROPURINE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2012-07-18 — — EP disclosed
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-07-05 — — US disclosed
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-07-05 — — US disclosed
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE FAAH, FAAH2, TPMT PDE3B 1086/4885PDE3A 1005/4885ALDH1A1 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback